Pfizer Inc Stock Performance

PFE Stock  USD 25.86  0.64  2.42%   
Pfizer has a performance score of 10 on a scale of 0 to 100. The company holds a Beta of 0.83, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pfizer's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pfizer is expected to be smaller as well. Pfizer Inc right now holds a risk of 1.41%. Please check Pfizer Inc total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to decide if Pfizer Inc will be following its historical price patterns.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Pfizer may actually be approaching a critical reversion point that can send shares even higher in February 2026. ...more

Actual Historical Performance (%)

One Day Return
2.34
Five Day Return
2.26
Year To Date Return
5.18
Ten Year Return
(8.45)
All Time Return
6.1 K
Forward Dividend Yield
0.0665
Payout Ratio
0.587
Last Split Factor
1054:1000
Forward Dividend Rate
1.72
Dividend Date
2026-03-06
 
Pfizer dividend paid on 1st of December 2025
12/01/2025
1
Pfizer Partners with Boltz to Use AI in Drug Discovery
01/08/2026
2
Evotec Is Up 17.3 percent After Landing 250m Sanofi Alliance And IR Overhaul Has The Bull Case Changed
01/13/2026
3
Pet Flavors Adds Randolph Legg to Board, Joining Fabian Kausche
01/16/2026
4
Pfizer Outperforms Broader Market What You Need to Know
01/21/2026
5
Texas AG Starts Investigation Into Vaccine-Related Financial Incentives
01/22/2026
6
The Top Stock to Buy With 30 for 2026
01/23/2026
7
Startup Fortitude Bio Launches to Beat Drug Resistance in Cancer, Expand ADCs to Autoimmune Disease
01/26/2026
Begin Period Cash Flow2.9 B
Total Cashflows From Investing Activities2.7 B

Pfizer Relative Risk vs. Return Landscape

If you would invest  2,348  in Pfizer Inc on October 30, 2025 and sell it today you would earn a total of  254.00  from holding Pfizer Inc or generate 10.82% return on investment over 90 days. Pfizer Inc is generating 0.1782% of daily returns assuming volatility of 1.4066% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than Pfizer, and above 97% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Pfizer is expected to generate 1.88 times more return on investment than the market. However, the company is 1.88 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

Pfizer Target Price Odds to finish over Current Price

The tendency of Pfizer Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 25.86 90 days 25.86 
about 5.09
Based on a normal probability distribution, the odds of Pfizer to move above the current price in 90 days from now is about 5.09 (This Pfizer Inc probability density function shows the probability of Pfizer Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Pfizer has a beta of 0.83 indicating as returns on the market go up, Pfizer average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pfizer Inc will be expected to be much smaller as well. Additionally Pfizer Inc has an alpha of 0.0984, implying that it can generate a 0.0984 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Pfizer Price Density   
       Price  

Predictive Modules for Pfizer

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pfizer Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
25.2026.5927.98
Details
Intrinsic
Valuation
LowRealHigh
23.8528.5029.89
Details
Naive
Forecast
LowNextHigh
25.3926.7928.18
Details
25 Analysts
Consensus
LowTargetHigh
26.0828.6631.81
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pfizer. Your research has to be compared to or analyzed against Pfizer's peers to derive any actionable benefits. When done correctly, Pfizer's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Pfizer Inc.

Pfizer Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Pfizer is not an exception. The market had few large corrections towards the Pfizer's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pfizer Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pfizer within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.1
β
Beta against Dow Jones0.83
σ
Overall volatility
0.66
Ir
Information ratio 0.06

Pfizer Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pfizer for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pfizer Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Pfizer Inc has a strong financial position based on the latest SEC filings
About 68.0% of the company shares are owned by institutional investors
On 1st of December 2025 Pfizer paid $ 0.43 per share dividend to its current shareholders
Latest headline from medcitynews.com: Startup Fortitude Bio Launches to Beat Drug Resistance in Cancer, Expand ADCs to Autoimmune Disease

Pfizer Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pfizer Stock often depends not only on the future outlook of the current and potential Pfizer's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pfizer's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding5.7 B
Cash And Short Term Investments20.5 B

Pfizer Fundamentals Growth

Pfizer Stock prices reflect investors' perceptions of the future prospects and financial health of Pfizer, and Pfizer fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pfizer Stock performance.

About Pfizer Performance

By analyzing Pfizer's fundamental ratios, stakeholders can gain valuable insights into Pfizer's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pfizer has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pfizer has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 209.11  238.48 
Return On Tangible Assets 0.08  0.10 
Return On Capital Employed 0.11  0.22 
Return On Assets 0.04  0.04 
Return On Equity 0.10  0.10 

Things to note about Pfizer Inc performance evaluation

Checking the ongoing alerts about Pfizer for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pfizer Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Pfizer Inc has a strong financial position based on the latest SEC filings
About 68.0% of the company shares are owned by institutional investors
On 1st of December 2025 Pfizer paid $ 0.43 per share dividend to its current shareholders
Latest headline from medcitynews.com: Startup Fortitude Bio Launches to Beat Drug Resistance in Cancer, Expand ADCs to Autoimmune Disease
Evaluating Pfizer's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Pfizer's stock performance include:
  • Analyzing Pfizer's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pfizer's stock is overvalued or undervalued compared to its peers.
  • Examining Pfizer's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Pfizer's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pfizer's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Pfizer's stock. These opinions can provide insight into Pfizer's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Pfizer's stock performance is not an exact science, and many factors can impact Pfizer's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamental Analysis
View fundamental data based on most recent published financial statements
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data